Nanoviricides, Inc.
NNVC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001379006
No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Nanoviricides, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 33 | 35 | +2 |
| Shares | 1.34M | 1.43M | +94.0K (+7.0%) |
| Value | $1.87M | $2.04M | +$174.8K (+9.4%) |
New holders (7)
Institutions that held Nanoviricides, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 52,217 | $74.7K | 0.00% |
| Citadel Advisors LLC | 16,761 | $24.0K | 0.00% |
| TRUE Private Wealth Advisors | 10,000 | $14.3K | 0.00% |
| Citigroup Inc | 5,266 | $7.53K | 0.00% |
| Advisory Services Network, LLC | 3,000 | $4.29K | 0.00% |
| Simplex Trading, LLC | 2,110 | $3.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 823 | $1.18K | 0.00% |
Sold out (5)
Institutions that held Nanoviricides, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Virtu Financial LLC | 49,235 | $69.0K |
| Royal Bank of Canada | 30,535 | $43.0K |
| Wells Fargo & Company | 1,000 | $1.40K |
| Raymond James Financial Inc | 44 | $62 |
| Harbour Investments, Inc. | 25 | $35 |